An official American Thoracic Society/European Respiratory Society statement

Research questions in COPD

ATS/ERS Task Force for COPD Research

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality, and resource use worldwide. The goal of this official American Thoracic Society (ATS)/European Respiratory Society (ERS) research statement is to describe evidence related to diagnosis, assessment and management; identify gaps in knowledge; and make recommendations for future research. It is not intended to provide clinical practice recommendations on COPD diagnosis and management. Clinicians, researchers, and patient advocates with expertise in COPD were invited to participate. A literature search of Medline was performed, and studies deemed relevant were selected. The search was not a systematic review of the evidence. Existing evidence was appraised and summarised, and then salient knowledge gaps were identified. Recommendations for research that addresses important gaps in the evidence in all areas of COPD were formulated via discussion and consensus. Great strides have been made in the diagnosis, assessment and management of COPD, as well as understanding its pathogenesis. Despite this, many important questions remain unanswered. This ATS/ERS research statement highlights the types of research that leading clinicians, researchers, and patient advocates believe will have the greatest impact on patient-centred outcomes.

Original languageEnglish (US)
Pages (from-to)879-905
Number of pages27
JournalEuropean Respiratory Journal
Volume45
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Chronic Obstructive Pulmonary Disease
Research
Research Personnel
Disease Management
Thorax
Morbidity
Mortality

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

An official American Thoracic Society/European Respiratory Society statement : Research questions in COPD. / ATS/ERS Task Force for COPD Research.

In: European Respiratory Journal, Vol. 45, No. 4, 01.04.2015, p. 879-905.

Research output: Contribution to journalArticle

@article{42f4de7412404c0a82869fc6580e023a,
title = "An official American Thoracic Society/European Respiratory Society statement: Research questions in COPD",
abstract = "Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality, and resource use worldwide. The goal of this official American Thoracic Society (ATS)/European Respiratory Society (ERS) research statement is to describe evidence related to diagnosis, assessment and management; identify gaps in knowledge; and make recommendations for future research. It is not intended to provide clinical practice recommendations on COPD diagnosis and management. Clinicians, researchers, and patient advocates with expertise in COPD were invited to participate. A literature search of Medline was performed, and studies deemed relevant were selected. The search was not a systematic review of the evidence. Existing evidence was appraised and summarised, and then salient knowledge gaps were identified. Recommendations for research that addresses important gaps in the evidence in all areas of COPD were formulated via discussion and consensus. Great strides have been made in the diagnosis, assessment and management of COPD, as well as understanding its pathogenesis. Despite this, many important questions remain unanswered. This ATS/ERS research statement highlights the types of research that leading clinicians, researchers, and patient advocates believe will have the greatest impact on patient-centred outcomes.",
author = "{ATS/ERS Task Force for COPD Research} and Celli, {Bartolome R.} and Marc Decramer and Wedzicha, {Jadwiga A.} and Wilson, {Kevin C.} and Alvar Agust{\'i} and Criner, {Gerard J.} and William MacNee and Make, {Barry J.} and Rennard, {Stephen I.} and Rennard, {Stephen Israel} and Claus Vogelmeier and Antonio Anzueto and Au, {David H.} and Barnes, {Peter J.} and Burgel, {Pierre Regis} and Calverley, {Peter M.} and Ciro Casanova and Clini, {Enrico M.} and Cooper, {Christopher B.} and Coxson, {Harvey O.} and Dusser, {Daniel J.} and Fabbri, {Leonardo M.} and Bonnie Fahy and Ferguson, {Gary T.} and Andrew Fisher and Fletcher, {Monica J.} and Maurice Hayot and Hurst, {John R.} and Jones, {Paul W.} and Mahler, {Donald A.} and Fran{\cc}ois Maltais and Mannino, {David M.} and Martinez, {Fernando J.} and Marc Miravitlles and Meek, {Paula M.} and Alberto Papi and Rabe, {Klaus F.} and Nicolas Roche and Sciurba, {Frank C.} and Sanjay Sethi and Nikos Siafakas and Sin, {Don D.} and Soriano, {Joan B.} and Stoller, {James K.} and Tashkin, {Donald P.} and Thierry Troosters and Verleden, {Geert M.} and Johny Verschakelen and Jorgen Vestbo and Walsh, {John W.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1183/09031936.00009015",
language = "English (US)",
volume = "45",
pages = "879--905",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "4",

}

TY - JOUR

T1 - An official American Thoracic Society/European Respiratory Society statement

T2 - Research questions in COPD

AU - ATS/ERS Task Force for COPD Research

AU - Celli, Bartolome R.

AU - Decramer, Marc

AU - Wedzicha, Jadwiga A.

AU - Wilson, Kevin C.

AU - Agustí, Alvar

AU - Criner, Gerard J.

AU - MacNee, William

AU - Make, Barry J.

AU - Rennard, Stephen I.

AU - Rennard, Stephen Israel

AU - Vogelmeier, Claus

AU - Anzueto, Antonio

AU - Au, David H.

AU - Barnes, Peter J.

AU - Burgel, Pierre Regis

AU - Calverley, Peter M.

AU - Casanova, Ciro

AU - Clini, Enrico M.

AU - Cooper, Christopher B.

AU - Coxson, Harvey O.

AU - Dusser, Daniel J.

AU - Fabbri, Leonardo M.

AU - Fahy, Bonnie

AU - Ferguson, Gary T.

AU - Fisher, Andrew

AU - Fletcher, Monica J.

AU - Hayot, Maurice

AU - Hurst, John R.

AU - Jones, Paul W.

AU - Mahler, Donald A.

AU - Maltais, François

AU - Mannino, David M.

AU - Martinez, Fernando J.

AU - Miravitlles, Marc

AU - Meek, Paula M.

AU - Papi, Alberto

AU - Rabe, Klaus F.

AU - Roche, Nicolas

AU - Sciurba, Frank C.

AU - Sethi, Sanjay

AU - Siafakas, Nikos

AU - Sin, Don D.

AU - Soriano, Joan B.

AU - Stoller, James K.

AU - Tashkin, Donald P.

AU - Troosters, Thierry

AU - Verleden, Geert M.

AU - Verschakelen, Johny

AU - Vestbo, Jorgen

AU - Walsh, John W.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality, and resource use worldwide. The goal of this official American Thoracic Society (ATS)/European Respiratory Society (ERS) research statement is to describe evidence related to diagnosis, assessment and management; identify gaps in knowledge; and make recommendations for future research. It is not intended to provide clinical practice recommendations on COPD diagnosis and management. Clinicians, researchers, and patient advocates with expertise in COPD were invited to participate. A literature search of Medline was performed, and studies deemed relevant were selected. The search was not a systematic review of the evidence. Existing evidence was appraised and summarised, and then salient knowledge gaps were identified. Recommendations for research that addresses important gaps in the evidence in all areas of COPD were formulated via discussion and consensus. Great strides have been made in the diagnosis, assessment and management of COPD, as well as understanding its pathogenesis. Despite this, many important questions remain unanswered. This ATS/ERS research statement highlights the types of research that leading clinicians, researchers, and patient advocates believe will have the greatest impact on patient-centred outcomes.

AB - Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality, and resource use worldwide. The goal of this official American Thoracic Society (ATS)/European Respiratory Society (ERS) research statement is to describe evidence related to diagnosis, assessment and management; identify gaps in knowledge; and make recommendations for future research. It is not intended to provide clinical practice recommendations on COPD diagnosis and management. Clinicians, researchers, and patient advocates with expertise in COPD were invited to participate. A literature search of Medline was performed, and studies deemed relevant were selected. The search was not a systematic review of the evidence. Existing evidence was appraised and summarised, and then salient knowledge gaps were identified. Recommendations for research that addresses important gaps in the evidence in all areas of COPD were formulated via discussion and consensus. Great strides have been made in the diagnosis, assessment and management of COPD, as well as understanding its pathogenesis. Despite this, many important questions remain unanswered. This ATS/ERS research statement highlights the types of research that leading clinicians, researchers, and patient advocates believe will have the greatest impact on patient-centred outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84926435248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926435248&partnerID=8YFLogxK

U2 - 10.1183/09031936.00009015

DO - 10.1183/09031936.00009015

M3 - Article

VL - 45

SP - 879

EP - 905

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 4

ER -